Virtus LifeSci Biotech Clinical Trials ETF Rating $18.32 -0.34 (-1.82%) As of 04/25/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy 2.96Holdings in BBC have an aggregate rating of Moderate Buy based on 395 analyst ratings issued in the past year covering 49 companies (52.4% of the portfolio).BBC Aggregate Price Target$18.32High Prediction$18.32Average Prediction$18.32Low Prediction$18.32Holdings in BBC have an aggregate price target of $18.32 and a range of $18.32 to $18.32 covering 49 companies (52.4% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy31 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.78%SLNOSoleno Therapeutics$73.26-1.3%4.652 of 5 stars3.20$104.67 42.9%10Analyst ForecastPositive News1.69%SMMTSummit Therapeutics$23.47-36.0%2.6563 of 5 stars3.00$36.70 56.4%10Upcoming EarningsAnalyst ForecastNews CoverageGap DownHigh Trading Volume1.65%ANABAnaptysBio$20.70+0.4%2.169 of 5 stars2.70$33.63 62.4%10Positive News1.56%AKROAkero Therapeutics$41.00+0.0%4.1728 of 5 stars3.00$76.29 86.1%9Positive NewsGap Up1.45%LQDALiquidia$14.12+0.6%2.8527 of 5 stars3.11$26.63 88.6%9News CoveragePositive News1.42%XERSXeris Biopharma$4.31+0.7%4.2905 of 5 stars2.80$6.10 41.5%5Positive News1.36%PTGXProtagonist Therapeutics$44.49-0.8%3.4255 of 5 stars3.00$65.44 47.1%9News CoveragePositive News1.32%ARQTArcutis Biotherapeutics$14.61-0.7%2.9378 of 5 stars2.83$18.80 28.7%6Positive News1.30%MLYSMineralys Therapeutics$13.34-5.3%2.4719 of 5 stars3.00$33.00 147.4%3Short Interest ↑1.25%MRUSMerus$43.57-1.8%3.4276 of 5 stars3.13$85.31 95.8%16Short Interest ↓Positive News1.20%CVACCureVac$3.23-0.9%3.9736 of 5 stars3.00$16.00 395.4%1Gap Up1.12%ZYMEZymeworks$12.57+0.4%2.7333 of 5 stars2.88$21.00 67.1%8News CoveragePositive News1.09%SVRASavara$3.18-2.8%1.7202 of 5 stars2.83$8.83 177.8%6Positive News1.08%ABUSArbutus Biopharma$3.29-1.5%1.9955 of 5 stars3.00$5.50 67.2%4Upcoming EarningsNews Coverage1.06%QUREuniQure$14.18-0.6%2.3781 of 5 stars2.82$38.80 173.6%11Short Interest ↑1.06%SNDXSyndax Pharmaceuticals$13.33+0.2%3.6491 of 5 stars2.90$36.20 171.6%10Positive NewsGap Up1.05%XENEXenon Pharmaceuticals$37.62-1.5%2.8065 of 5 stars3.00$56.78 50.9%10Analyst UpgradeNews CoveragePositive News1.04%DNTHDianthus Therapeutics$21.67+2.1%1.7765 of 5 stars3.22$54.33 150.7%9Positive News1.03%BLTEBelite Bio$58.23-2.3%2.9091 of 5 stars3.00$96.67 66.0%4Positive News1.01%RNAAvidity Biosciences$30.84-0.3%2.8136 of 5 stars3.00$66.69 116.3%13News CoveragePositive News1.00%ITOSiTeos Therapeutics$7.35-1.5%2.4166 of 5 stars3.00$25.75 250.3%4Positive News1.00%ABCLAbCellera Biologics$2.57-1.2%2.5796 of 5 stars2.67$7.50 191.8%3Positive News1.00%CAPRCapricor Therapeutics$13.03-1.9%1.8443 of 5 stars3.00$34.50 164.8%60.99%CELCCelcuity$10.80-2.2%2.635 of 5 stars3.14$30.17 179.3%7Short Interest ↓Positive News0.98%RVMDRevolution Medicines$38.77+0.5%3.7907 of 5 stars3.00$66.67 72.0%12News CoveragePositive News0.97%MNMDMind Medicine (MindMed)$6.23-3.1%2.5121 of 5 stars3.23$25.11 303.1%13Positive News0.97%NUVLNuvalent$73.48-0.7%1.9183 of 5 stars2.90$115.50 57.2%10News CoveragePositive News0.96%ETNB89bio$6.94+0.6%2.8463 of 5 stars2.89$27.25 292.7%9Analyst ForecastOptions VolumeNews CoveragePositive News0.95%OMEROmeros$7.31+0.1%3.7834 of 5 stars2.80$22.50 207.8%50.94%LENZLENZ Therapeutics$26.87-6.1%1.8587 of 5 stars3.17$46.60 73.4%6Positive News0.93%KROSKeros Therapeutics$14.21-1.5%3.0939 of 5 stars2.57$40.33 183.8%14News CoveragePositive News0.93%SANASana Biotechnology$1.771.8941 of 5 stars2.86$10.80 510.2%7Analyst Forecast0.93%RXRXRecursion Pharmaceuticals$5.73-0.3%2.2402 of 5 stars2.33$8.20 43.1%6Gap Down0.92%VERVVerve Therapeutics$5.76-0.3%3.7228 of 5 stars3.00$25.75 347.0%6Positive News0.92%RGNXREGENXBIO$9.15-0.5%4.4666 of 5 stars2.83$31.63 245.6%6News CoveragePositive News0.92%CMPSCOMPASS Pathways$3.82-4.3%2.2037 of 5 stars3.00$20.20 428.8%6News CoveragePositive News0.91%CYTKCytokinetics$40.43+0.2%4.122 of 5 stars2.94$79.13 95.7%18Analyst ForecastNews Coverage0.91%AVBPArriVent BioPharma$20.82-1.7%1.0843 of 5 stars3.17$39.00 87.3%6Short Interest ↑Positive News0.91%PHVSPharvaris$16.84+6.4%2.2439 of 5 stars3.00$42.67 153.4%3Positive NewsHigh Trading Volume0.90%VIRVir Biotechnology$6.12-2.7%2.6301 of 5 stars2.86$33.57 448.6%7Upcoming EarningsNews Coverage0.90%NUVBNuvation Bio$2.133.5885 of 5 stars3.17$7.83 267.8%6Analyst ForecastPositive News0.89%EYPTEyePoint Pharmaceuticals$6.37-2.6%1.6991 of 5 stars3.00$26.63 318.0%9News CoveragePositive News0.89%MLTXMoonLake Immunotherapeutics$39.42-0.1%1.5653 of 5 stars3.00$80.50 104.2%8News Coverage0.89%APGEApogee Therapeutics$36.85-0.5%2.1656 of 5 stars3.00$92.17 150.1%6News CoveragePositive NewsGap Down0.89%TRMLTourmaline Bio$16.89-2.5%2.4549 of 5 stars3.00$49.33 192.1%7Analyst ForecastAnalyst RevisionNews Coverage0.88%VRDNViridian Therapeutics$13.50-0.4%1.2683 of 5 stars2.75$35.70 164.4%12Analyst ForecastNews CoveragePositive News0.88%ACLXArcellx$63.71-0.4%1.8713 of 5 stars3.14$110.67 73.7%14News CoveragePositive NewsGap Down0.87%GPCRStructure Therapeutics$23.74+0.4%2.0337 of 5 stars3.00$81.29 242.4%8Analyst ForecastNews Coverage0.86%CNTACentessa Pharmaceuticals$13.79+1.3%2.5476 of 5 stars3.00$27.71 101.0%8Insider TradeNews CoveragePositive News This page (NYSEARCA:BBC) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBC Stock Free BBC Stock Alerts